Outcomes of intermediate or high‐risk CMML patients treated with hypomethylating agents combined with venetoclax: A single center experience

• Main Authors: Chao Li (Author), ChengXin Deng (Author), Ping Wu (Author), KaiFan Liu (Author), Xin Huang (Author), MingMin Li (Author), XiaoMei Chen (Author), SuXia Geng (Author), PeiLong Lai (Author), JianYu Weng (Author), Xin Du (Author)
• Format: Book
• Published: Wiley, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Chronic myelomonocytic leukemia (CMML) treatment remains a pressing clinical challenge. We conducted a retrospective analysis on 52 CMML cases, exploring the effectiveness of combining venetoclax (Vene) with hypomethylating agents (HMAs). The study's findings show promise: the HMAs plu...